Post-transplantation anaemia in adult and paediatric renal allograft recipients - Guy's Hospital experience

Nephrology Dialysis Transplantation

Volumn 21, Issue 7, 2006, Pages 1974-1980

  Al Khoury, Salam ^a   Shah, Nilesh ^a   Afzali, Behdad ^a   Covic, Adrian ^a   Taylor, Judy ^a   Goldsmith, David ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Adult; Age; Female sex; Ferritin; Graft function; Mycophenolate mofetil; Paediatric; Post transplantation anaemia; Sirolimus

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN; TACROLIMUS;

ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ARTICLE; CHEMICAL PARAMETERS; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DISEASE ACTIVITY; ELECTRONIC MEDICAL RECORD; ERYTHROPOIESIS; EXPERIENCE; FEMALE; FERRITIN BLOOD LEVEL; GENDER; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ROMANIA; WORLD HEALTH ORGANIZATION;

ADULT; ANEMIA; CHILD; COHORT STUDIES; FEMALE; FERRITINS; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; SIROLIMUS;

EID: 33745615100     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl121     Document Type: Article

References (23)

1. Roger SD, McMahon LP, Clarkson A et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial. J Am Soc Nephrol 2004; 15: 148-156
2. Locatelli F, Pisoni RL, Combe C et al. Anaemia in haemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121-132
3. Gouva C, Nikolopoulos P, Ioannidis JP et al. Treating anaemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int 2004; 66: 753-760
4. Silverberg DS, Wexler D, Blum B et al. Anaemia in chronic kidney disease and congestive heart failure. Blood Purif 2003; 21: 124-130
5. Snyder JJ, Foley RN, Gilbertson DT et al. Haemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States. J Am Soc Nephrol 2004; 15: 174-179
6. Macdougall IC. Erythropoietin and renal failure. Curr Hematol Rep 2003; 2: 459-464
7. Vanrenterghem Y, Ponticelli C, Morales JM et al. Prevalence and management of anaemia in renal transplant recipients: A European survey. Am J Transplant 2003; 3: 835-845
8. Moore LW, Smith SO, Winsett RP et al. Factors affecting erythropoietin production and correction of anaemia in kidney transplant recipients. Clin Transplant 1994; 8: 358-364
9. Shibagaki Y, Shetty A. Anaemia is common after kidney transplantation, especially among African Americans. Nephrol Dial Transplant 2004; 19: 2368-2373
10. Vanrenterghem Y. Anaemia after renal transplantation. Nephrol Dial Transplant 2004; 19 [Suppl 5]: V54-V58
11. Al-Uzri A, Yorgin PD, Kling PJ. Anaemia in children after transplantation: Etiology and the effect of immunosuppressive therapy on erythropoiesis. Pediatr Transplant 2003 7: 253-264
12. Kausman JY, Powell HR, Jones CL. Anaemia in paediatric renal transplant recipients. Pediatr Nephrol 2004; 19: 526-530
13. Mix TC, Kazmi W, Khan S et al. Anaemia: A continuing problem following kidney transplantation. Am J Transplant 2003; 3: 1426-1433
14. Karthikeyan V, Karpinski J, Nair RC et al. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004; 4: 262-269
15. Rao M, Muirhead N, Buoncristiani U. Management of anaemia. Contrib Nephrol 2004; 145: 69-74
16. Leijn E, Monnens LA, Cornelissen EA. Intravenous iron supplementation in children on hemodialysis. J Nephrol 2004; 17: 423-426
17. Karakus S, Kanbay M, Koseoglu HK et al. Causes of anaemia in renal transplant recipients. Transplant Proc 2004; 36: 164-165
18. Mathew TH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1998; 65: 1450-1454
19. Wang K, Zhang H, Li Y et al. Safety of mycophenolate mofetil versus azathioprine in renal transplantation: A systematic review. Transplant Proc 2004; 36: 2068-2070
20. Hricik DE. Anaemia after kidney transplantation - is the incidence increasing? Am J Transplant 2003; 3: 771-772
21. Kreis H, Cisterne JM, Land W et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000; 69: 1252-1260
22. Afzali B, Shah S, Chowdhury P et al. Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy. Transplantation 2005; 79: 304-309
23. Inigo P, Campistol JM, Saracho R et al. Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study. Nephron Clin Pract 2003; 95: C84-c90